MedTrace Logo

Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort

NCT01816880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2015-10-16

No results posted yet for this study

Summary

The aim of this sub-study is to determine whether healthy individuals over 90 years of age possess immune cells that are involved in protection from chronic disease. The immune system is well known to produce anti-cancer and other immune cells, called antibodies that can be beneficial to our health. In this study the investigators will evaluate the immune status of the healthy individuals over 90 years of age. The investigators will be focused on studying molecules known to be involved in cholesterol, cancer like those for prostate cancer and breast cancer, inflammatory diseases, and infectious diseases like influenza.

Conditions

  • Antibodies Involved in Healthy Aging

Sponsors & Collaborators

  • Scripps Translational Science Institute

    lead OTHER

Principal Investigators

  • Eric Topol, MD · Scripps

Eligibility

Min Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01816880 on ClinicalTrials.gov